Pharmacological characterization of a novel potent, selective, and orally active orexin 2 receptor antagonist, SDM‐878

por Maehara, Shunsuke, Yuge, Natsuko, Higashi, Chika, Ota, Takumi, Furukawa, Junji, Takeuchi, Takashi
Publicado 2020

Intestine-Targeted DGAT1 Inhibition Improves Obesity and Insulin Resistance without Skin Aberrations in Mice

por Tsuda, Naoto, Kumadaki, Shin, Higashi, Chika, Ozawa, Makoto, Shinozaki, Mikihiko, Kato, Yutaka, Hoshida, Koutarou, Kikuchi, Satomi, Nakano, Yoshihisa, Ogawa, Yoshihiro, Furusako, Shoji
Publicado 2014

Acute Kidney Injury Caused by Evans Syndrome with Systemic Lupus Erythematosus and Systemic Sclerosis

por Matsuoka, Natsumi, Watanabe, Haruki, Kurooka, Naoko, Kato, Sumari, Higashi, Chika, Tanabe, Katsuyuki, Kinomura, Masaru, Fujii, Nobuharu, Sada, Ken-ei, Sugiyama, Hitoshi, Wada, Jun
Publicado 2020

A novel free fatty acid receptor 1 (GPR40/FFAR1) agonist, MR1704, enhances glucose‐dependent insulin secretion and improves glucose homeostasis in rats

por Tsuda, Naoto, Kawaji, Atsuko, Sato, Toshihiro, Takagi, Mitsuhiro, Higashi, Chika, Kato, Yutaka, Ogawa, Kumiko, Naba, Hiroyasu, Ohkouchi, Munetaka, Nakamura, Masaki, Hosaka, Yoshitaka, Sakaki, Junichi
Publicado 2017